Delivery Order SPE2DB22D9239-SPE2DB24FDM60

Award Date 9/16/24
Potential Completion Date 10/7/24
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price delivery order is for the supply of 4565675719 CERDELGA 84 MG CAPSULE 14S, with an ultimate completion date of August 6, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $32,185.93 and has an ultimate completion date of March 7, 2025. The award is for the delivery of CERDELGA 84 MG CAPSULE 14S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $32,185.93, is for the supply of CERDELGA 84 MG CAPSULE 14S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price delivery order is for the supply of CERDELGA 84 MG CAPSULE 14S. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $32,185.93, is for the delivery of CERDELGA 84 MG CAPSULE 14S, a specialized pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,185.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 84mg capsules of the pharmaceutical product CERDELGA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $32,185.93, is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product, with a period of performance through April 30, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product CERDELGA 84 MG CAPSULE 14S, with a completion date of May 1, 2024 and a ceiling value of $32,185.93. The award is associated with a larger indefinite delivery vehicle contract, SPE2DB, which has a ceiling of up to $4,999,999 and enables DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) organization. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product. The contract has a completion date of February 16, 2024. DMS Pharmaceutical Group Inc. holds a broader indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, for the supply of a wide range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S and has an ultimate completion date of April 4, 2024. The contract is part of a larger indefinite delivery vehicle (IDV) contract, 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 that enables DLA to...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDM60
    Delivery Order

This federal contract award is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

The contract is a firm fixed-price delivery order with a ceiling value of $32,185.93 and an ultimate completion date of October 7, 2024. It is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide. This IDC, under the SPE2DB program, is a crucial vehicle for DMS Pharmaceutical Group to supply both routine and specialized medications to the Department of Defense.

Generated 12/16/24, 2:19 PM